Micrima
Micrima is redefining breast cancer diagnostics by providing a new breast tissue analysis method that quickly and safely produces breast density data. This enables personalized imaging and accurate breast cancer risk assessment for all women. Their medical device, Mi~Scan®, utilizes radio frequency and AI to analyze breast tissue properties, providing BI-RADS breast density classification and other insights. This data is integrated with leading breast cancer risk calculation models in their Mi~Score® software. Micrima aims to improve outcomes and support proactive, informed decisions in women's healthcare, ensuring women are aware of their breast cancer risk. The technology was originally developed for landmine detection and has been adapted for breast cancer detection over nearly 20 years.
Micrima
Micrima is redefining breast cancer diagnostics by providing a new breast tissue analysis method that quickly and safely produces breast density data. This enables personalized imaging and accurate breast cancer risk assessment for all women. Their medical device, Mi~Scan®, utilizes radio frequency and AI to analyze breast tissue properties, providing BI-RADS breast density classification and other insights. This data is integrated with leading breast cancer risk calculation models in their Mi~Score® software. Micrima aims to improve outcomes and support proactive, informed decisions in women's healthcare, ensuring women are aware of their breast cancer risk. The technology was originally developed for landmine detection and has been adapted for breast cancer detection over nearly 20 years.